Assessing the role of Positron Emission Tomography (PET) scanning to assess early response to treatment in advanced breast cancer.
Not Applicable
- Conditions
- Breast CancerCancer - Breast
- Registration Number
- ACTRN12612001044819
- Lead Sponsor
- Alfred Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Stopped early
- Sex
- Female
- Target Recruitment
- 5
Inclusion Criteria
Histologically confirmed Metastatic Breast Cancer
Planned to Receive palliative chemotherapy/tumour targeted agents
Exclusion Criteria
Age < 18
Concurrent active cancer other than non melanotic skin cancer or locally invasive cervical cancer
Significant uncontrolled intercurrent illness
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method